On this podcast leading scientist, clinicians and entrepreneurs share their thoughts on the progress of personalized medicine. With our guests, we discuss new technologies for targeted treatments and diagnostics, their benefits for patients and clinicians and related implementation challenges.
All content for Personalized Medicine Podcast is the property of Oleksandr Yagensky and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On this podcast leading scientist, clinicians and entrepreneurs share their thoughts on the progress of personalized medicine. With our guests, we discuss new technologies for targeted treatments and diagnostics, their benefits for patients and clinicians and related implementation challenges.
Ep#043: Developing Precision Medicines Using Cryo-EM with Dr. Sriram Subramaniam
Personalized Medicine Podcast
43 minutes
3 years ago
Ep#043: Developing Precision Medicines Using Cryo-EM with Dr. Sriram Subramaniam
In this episode we dive deep into the world of structural biology. We discuss the role of cryogenic electron microscopy in the development of precision medicines with the founder and CEO of Gandeeva Therapeutics, Dr. Sriram Subramaniam. Cryo-EM opened a new way to study drug-target interactions and is changing the way we develop new therapies.
Tune into our interview with Sriram to learn more about:
◦ The founding story of Gandeeva Therapeutics
◦ The evolution of Cryo-EM technology
◦ Application of Cryo-EM in drug discovery
◦ Advantages of Cryo-EM over crystallography im mapping protein structures
◦ Making sense of experimental data with AI and machine learning
◦ The future of personalized medicine and role of structural biology in it
◦ Sriram's advice for budding life science entrepreneurs
Personalized Medicine Podcast
On this podcast leading scientist, clinicians and entrepreneurs share their thoughts on the progress of personalized medicine. With our guests, we discuss new technologies for targeted treatments and diagnostics, their benefits for patients and clinicians and related implementation challenges.
